Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ /Jo*O=Lpo
9]|cs
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© n}YRE`>D
}PoB`H'K5
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 4Sw)IU~K(
sqsBGFeG
1.Co-stimulators (or co-stimulating molecules) lh
.p`^v
l.FkX
2.NK-kB tL
LP2^_&
$2\OBc=
3.Immunoglobulin superfamily 2jaR_``=:
N U\B
4.antigen-presenting cell (APC) O$KLQ '0"n
'(~+
\
5.death domain p'!cGJL
)]?sCNb
6.CCR and CXCR <Knl6$B
M"1}"ex#
7.Lectin (or mitogen) &h')snp:#
O*X]oX
8.Clusters of differentiation, CD) Il,2^54q
;3 O0O
9.B7 family 7"FsW3an
}e
s
10.Cytotoxic T lymphocyte, CTL) t*iKkV^aE
;3'ta!.c
11.IL-15 and IL-15 receptor (IL-15R) F8S% \i
=#
<!s!
12.MHC restriction Se
{}OG)
]MKW5Kq
13.Affinity-chromatography tZB"(\
TgoaEufS<
14.Cyctosprin A, CsA 49W@?:b
s IJl9
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) *eK\W00
m&a.i
B
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© H|JPqBNRh
4YX/=
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 U[,."w]T
Lyo!}T
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 6?i]oy^X]p
42]hX9E
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ G9 v'a&
`1
A,sXfa
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Di)%vU
wz`\RHL
ÃâÒßѧרҵ£º ut
j7"{'k|
CiF(
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
B_Ul&V
~F"<N q
Ïû»¯ÄÚ¿Æ£º *qa.h
qas
/ <C{$Gu
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ kz_gR;"(Z
!\<
[}2}
ѪҺ²¡Ñ§×¨Òµ£º _ sqj~|K
"_^vQ1M]Z
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿